Display Settings:

Format

Send to:

Choose Destination
Neuropsychopharmacology. 2006 Mar;31(3):473-92.

ACNP Task Force report on SSRIs and suicidal behavior in youth.

Author information

  • 1Columbia University/New York State Psychiatric Institute, New York, NY 10032, USA. jjm@columbia.edu

Abstract

This Task Force report by the American College of Neuropsychopharmacology evaluates the safety and efficacy of selective serotonin reuptake inhibitor (SSRIs) antidepressants for depressed youth under 18 years. The report was undertaken after regulatory agencies in the United States and United Kingdom raised concerns in 2003 about the possibility that treatment of depression in children and adolescents with SSRIs may increase the risk of suicidal thinking or suicide attempts.

PMID:
16319919
[PubMed - indexed for MEDLINE]
Free full text
PubMed Commons home

PubMed Commons

0 comments
How to join PubMed Commons

    Supplemental Content

    Full text links

    Icon for Nature Publishing Group
    Loading ...
    Write to the Help Desk